We know where levocarnitine shines, where the signal is subtle, and when another tool would get you further
The decreased in GFR or albuminuria has been associated with the presence of nonalcoholic steatohepatitis or the severity of fibrosis, whereas improvement in liver histology is associated with improvement in CKD.75 arGLP1 improves insulin levels, regulates autophagy, inhibits hepatic neoglycogenesis, reduces hepatic fat content, plasma liver enzyme levels and hepatic histological improvements have been described with liraglutide and semaglutide.49,76 Likewise, epicardial and perirenal fat are associated with increased cardiorenal risk,77 so that the reduction in ectopic fat43 as demonstrated with the use of arGLP-1 has could be beneficial in CKD
Lets start with semaglutide, the active ingredient in Wegovy
NEW YORK The demand for GLP-1 medications is skyrocketing, with studies predicting the market will reach $13.6 billion globally by 2028 (source: Research and Markets)